日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

化疗耐药肿瘤细胞分泌组增强了三阴性乳腺癌的免疫抑制作用

Skourti Eleni, Seip Kotryna, Mensali Nadia, Jabeen Shakila, Juell Siri, Øynebråten Inger, Pettersen Solveig, Engebraaten Olav, Corthay Alexandre, Inderberg Else Marit, Dolznig Helmut, Mælandsmo Gunhild Mari, Egeland Eivind Valen, Prasmickaite Lina

Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response

ER阳性乳腺癌肿瘤免疫微环境的空间组织:治疗期间的重塑及其与临床反应的关系

Dahle, Maria Aanesland; Førde, Jan-Lukas; Egeland, Eivind Valen; Creason, Allison L; Watson, Cameron; Garred, Øystein; Prasmickaite, Lina; Mælandsmo, Gunhild M; Mills, Gordon B; Engebraaten, Olav; Haugen, Mads Haugland

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy

SRC家族是三阴性乳腺癌(对化疗产生耐药性)的治疗靶点。

Egeland, Eivind Valen; Seip, Kotryna; Skourti, Eleni; Øy, Geir Frode; Pettersen, Solveig J; Pandya, Abhilash D; Dahle, Maria A; Haugen, Mads H; Kristian, Alexander; Nakken, Sigve; Engebraaten, Olav; Mælandsmo, Gunhild M; Prasmickaite, Lina

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants

载卡巴他赛聚(2-烷基氰基丙烯酸酯)纳米颗粒变体的临床前疗效

Remya Valsalakumari, Abhilash D Pandya #, Lina Prasmickaite #, Audun Kvalvaag, Anne Grethe Myrann, Andreas K O Åslund, Marianne Steinsvik Kjos, Cristina Fontecha-Cuenca, Hajira B Haroon, Ana R S Ribeiro, Jutta Horejs-Hoeck, S Moein Moghimi, Ýrr Mørch, Tore Skotland, Kirsten Sandvig, Gunhild Mari Mæl

A combined experimental-computational approach uncovers a role for the Golgi matrix protein Giantin in breast cancer progression

实验与计算相结合的方法揭示了高尔基基质蛋白 Giantin 在乳腺癌进展中的作用

Salim Ghannoum, Damiano Fantini, Muhammad Zahoor, Veronika Reiterer, Santosh Phuyal, Waldir Leoncio Netto, Øystein Sørensen, Arvind Iyer, Debarka Sengupta, Lina Prasmickaite, Gunhild Mari Mælandsmo, Alvaro Köhn-Luque, Hesso Farhan

Breast cancer patient-derived explant cultures recapitulate in vivo drug responses

乳腺癌患者来源的外植体培养物重现体内药物反应

Solveig Pettersen, Geir Frode Øy, Eivind Valen Egeland, Siri Juell, Olav Engebråten, Gunhild Mari Mælandsmo, Lina Prasmickaite

AXL inhibition improves BRAF-targeted treatment in melanoma

AXL 抑制可改善黑色素瘤的 BRAF 靶向治疗

Marta Nyakas, Karianne Giller Fleten, Mads Haugland Haugen, Nikolai Engedal, Christina Sveen, Inger Nina Farstad, Vivi Ann Flørenes, Lina Prasmickaite #, Gunhild Mari Mælandsmo #, Kotryna Seip #

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen

使用 CRISPR 功能丧失筛查检测乳腺细胞中表型特异性治疗脆弱性

Anna Barkovskaya, Craig M Goodwin, Kotryna Seip, Bylgja Hilmarsdottir, Solveig Pettersen, Clint Stalnecker, Olav Engebraaten, Eirikur Briem, Channing J Der, Siver A Moestue, Thorarinn Gudjonsson, Gunhild M Maelandsmo, Lina Prasmickaite

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells

抑制 O-GlcNAc 转移酶可激活他莫昔芬耐药乳腺癌细胞中的肿瘤抑制基因表达

Anna Barkovskaya, Kotryna Seip, Lina Prasmickaite, Ian G Mills, Siver A Moestue, Harri M Itkonen

Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment

基质诱导的表型可塑性提供了表型特异性靶向性以改善黑色素瘤治疗

Kotryna Seip, Kjetil Jørgensen, Marco Vincent Haselager, Marco Albrecht, Mads Haugland Haugen, Eivind Valen Egeland, Philippe Lucarelli, Olav Engebraaten, Thomas Sauter, Gunhild Mari Mælandsmo, Lina Prasmickaite